DOI: 10.1055/s-00000054

Pharmacopsychiatry

Ausgabe 03 · Volume 26 · Juni 2016 DOI: 10.1055/s-006-31690


Abstracts of the XIIth Symposium of the AGNP Task Force on Therapeutic Drug Monitoring in Psychiatry
Bremen, Germany, 1st – 3rd June 2016

Local Organizing Commitee: Prof. Dr. W. N. Kühn-Velten, Prof. Dr. N. von Ahsen, Dr. Gabriela Zurek, Bremen – Steering Commitee of the Task Force TDM: Prof. Dr. G. Gründer, Aachen, Prof. Dr. Dr. E. Haen, Regensburg, Prof. Dr. C. Hiemke, Mainz
Abstracts (HTML) Autorenliste

Review

  • 85
    Eyre, H. A.; Lavretsky, H.; Kartika, J.; Qassim, A.; Baune, B. T.:

    Modulatory Effects of Antidepressant Classes on the Innate and Adaptive Immune System in Depression

    • Original Paper

  • 97
    Matsui, Y.; Matsunaga, S.; Matsuda, Y.; Kishi, T.; Iwata, N.:

    Azapirones for Attention Deficit Hyperactivity Disorder: A Systematic Review

  • 107
    Zheng, W.; Xiang, Y.-Q.; Ng, C. H.; Ungvari, G. S.; Chiu, H. F. K.; Xiang, Y.-T.:

    Extract of Ginkgo biloba for Tardive Dyskinesia: Meta-analysis of Randomized Controlled Trials

  • 112
    Amiaz, R.; Rubinstein, K.; Czerniak, E.; Karni, Y.; Weiser, M.:

    A Diet and Fitness Program Similarly Affects Weight Reduction in Schizophrenia Patients Treated with Typical or Atypical Medications

  • 117
    Ji, S.; Li, A.; Wu, K.; Deng, C.; Dong, F.; Li, L.; Zhou, T.; Yue, W.; Wang, C.-Y.; Lu, W.:

    Brief Questionnaire Derived from PANSS Using a General Probability Model to Assess and Monitor the Clinical Features of Schizophrenia